Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 1
1950 1
1989 1
1991 1
1994 1
1995 1
1996 1
1998 2
1999 1
2000 1
2001 4
2002 1
2003 4
2004 3
2005 11
2006 5
2007 3
2008 4
2009 6
2010 6
2011 10
2012 8
2013 4
2014 14
2015 24
2016 26
2017 16
2018 16
2019 15
2020 12
2021 19
2022 11
2023 15
2024 15
2025 10
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Targeting a neoantigen derived from a common TP53 mutation.
Hsiue EH, Wright KM, Douglass J, Hwang MS, Mog BJ, Pearlman AH, Paul S, DiNapoli SR, Konig MF, Wang Q, Schaefer A, Miller MS, Skora AD, Azurmendi PA, Murphy MB, Liu Q, Watson E, Li Y, Pardoll DM, Bettegowda C, Papadopoulos N, Kinzler KW, Vogelstein B, Gabelli SB, Zhou S. Hsiue EH, et al. Among authors: hwang ms. Science. 2021 Mar 5;371(6533):eabc8697. doi: 10.1126/science.abc8697. Epub 2021 Mar 1. Science. 2021. PMID: 33649166 Free PMC article.
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Nichakawade TD, Ge J, Mog BJ, Lee BS, Pearlman AH, Hwang MS, DiNapoli SR, Wyhs N, Marcou N, Glavaris S, Konig MF, Gabelli SB, Watson E, Sterling C, Wagner-Johnston N, Rozati S, Swinnen L, Fuchs E, Pardoll DM, Gabrielson K, Papadopoulos N, Bettegowda C, Kinzler KW, Zhou S, Sur S, Vogelstein B, Paul S. Nichakawade TD, et al. Among authors: hwang ms. Nature. 2024 Apr;628(8007):416-423. doi: 10.1038/s41586-024-07233-2. Epub 2024 Mar 27. Nature. 2024. PMID: 38538786 Free PMC article.
Targeting public neoantigens for cancer immunotherapy.
Pearlman AH, Hwang MS, Konig MF, Hsiue EH, Douglass J, DiNapoli SR, Mog BJ, Bettegowda C, Pardoll DM, Gabelli SB, Papadopoulos N, Kinzler KW, Vogelstein B, Zhou S. Pearlman AH, et al. Among authors: hwang ms. Nat Cancer. 2021 May;2(5):487-497. doi: 10.1038/s43018-021-00210-y. Epub 2021 May 17. Nat Cancer. 2021. PMID: 34676374 Free PMC article. Review.
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.
Mog BJ, Marcou N, DiNapoli SR, Pearlman AH, Nichakawade TD, Hwang MS, Douglass J, Hsiue EH, Glavaris S, Wright KM, Konig MF, Paul S, Wyhs N, Ge J, Miller MS, Azurmendi P, Watson E, Pardoll DM, Gabelli SB, Bettegowda C, Papadopoulos N, Kinzler KW, Vogelstein B, Zhou S. Mog BJ, et al. Among authors: hwang ms. Sci Transl Med. 2024 Jul 10;16(755):eadg7123. doi: 10.1126/scitranslmed.adg7123. Epub 2024 Jul 10. Sci Transl Med. 2024. PMID: 38985855 Free PMC article.
Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements.
DiNapoli SR, Wright KM, Mog BJ, Pearlman AH, Nichakawade TD, Marcou N, Hsiue EH, Hwang MS, Douglass J, Liu Q, Watson E, Dal Molin M, Cohen JD, Popoli M, Paul S, Konig MF, Wyhs N, Azurmendi PA, Glavaris S, Ge J, Awosika TO, Liu J, Gabrielson KL, Gabelli SB, Pardoll DM, Bettegowda C, Papadopoulos N, Kinzler KW, Zhou S, Vogelstein B. DiNapoli SR, et al. Among authors: hwang ms. J Clin Invest. 2026 Jan 16;136(2):e192885. doi: 10.1172/JCI192885. eCollection 2026 Jan 16. J Clin Invest. 2026. PMID: 41542775 Free PMC article.
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.
Juric D, Song K, Johnson RM, Accordino MK, Bedard PL, Cervantes A, Gambardella V, Hamilton E, Italiano A, Kalinsky K, Krop IE, Oliveira M, Saura C, Schmid P, Turner NC, Varga A, Gendreau S, Hwang MS, Kuang Z, Lau JT, Lin E, Pham T, Maddalo D, Rees MG, Ronan MM, Roth JA, Martin S, Sodir NM, Sokol ES, Whitfield ZJ, Wong A, Yauch RL, Aimi J, Cheeti S, Fredrickson J, Hilz S, Hafner M, Hutchinson KE, Jin Y, Peters U, Zingg D, Royer-Joo S, Shankar N, Schutzman JL, Jhaveri KL, Dey A. Juric D, et al. Among authors: hwang ms. Clin Cancer Res. 2026 Jan 6;32(1):56-75. doi: 10.1158/1078-0432.CCR-25-1459. Clin Cancer Res. 2026. PMID: 41143603 Free PMC article. Clinical Trial.
Management of Large Facial Defects.
Rabbani CC, Hwang MS, Byrne PJ, Desai SC. Rabbani CC, et al. Among authors: hwang ms. Facial Plast Surg. 2020 Apr;36(2):148-157. doi: 10.1055/s-0040-1709179. Epub 2020 May 15. Facial Plast Surg. 2020. PMID: 32413922
Photon-triggered nanowire transistors.
Kim J, Lee HC, Kim KH, Hwang MS, Park JS, Lee JM, So JP, Choi JH, Kwon SH, Barrelet CJ, Park HG. Kim J, et al. Among authors: hwang ms. Nat Nanotechnol. 2017 Oct;12(10):963-968. doi: 10.1038/nnano.2017.153. Epub 2017 Aug 7. Nat Nanotechnol. 2017. PMID: 28785091
Lethal toxin-equipped effector cells for the potential treatment of cancer.
Pearlman AH, Mog BJ, Hwang MS, Rincon-Torroella J, DiNapoli SR, Paul S, Douglass J, Hsiue EH, Glavaris SA, Pardoll DM, Papadopoulos N, Kinzler KW, Bettegowda C, Zhou S, Vogelstein B, Konig MF. Pearlman AH, et al. Among authors: hwang ms. Proc Natl Acad Sci U S A. 2026 Mar 24;123(12):e2506991123. doi: 10.1073/pnas.2506991123. Epub 2026 Mar 16. Proc Natl Acad Sci U S A. 2026. PMID: 41838915 Free PMC article.
255 results